Clinical trial
Topiramate to Reduce Cocaine Dependence
NCT00223626 · Bankole Johnson, Other · Completed
Key facts
| NCT number | NCT00223626 |
|---|---|
| Title | Topiramate to Reduce Cocaine Dependence |
| Official title | Lab Trials to Develop Medication for Cocaine Dependence |
| Lead sponsor | Bankole Johnson, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 25 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: